For the quarter ended September 2025, Amrize Ltd (AMRZ) reported revenue of $3.68 billion, representing no change compared to the same period last year. EPS came in at $1.06, compared to $0 in the year-ago quarter.
The reported revenue represents a surprise of +5.28% over the Zacks Consensus Estimate of $3.49 billion. With the consensus EPS estimate being $1.01, the EPS surprise was +4.95%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Amrize Ltd performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Building Envelope: $901 million versus $896.07 million estimated by four analysts on average.
- Revenues- Building Materials: $2.77 billion compared to the $2.59 billion average estimate based on four analysts.
- Adjusted EBITDA- Building Envelope: $217 million versus $203.15 million estimated by four analysts on average.
- Adjusted EBITDA- Building Materials: $902 million versus $946.1 million estimated by four analysts on average.
View all Key Company Metrics for Amrize Ltd here>>>
Shares of Amrize Ltd have returned +4% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amrize Ltd (AMRZ): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
